|
2024 Book Chapter The role of the complement system in cancer etiology and managementSonderegger, Stefan E., Manzanero, Silvia, Woodruff, Trent M., Farouqa, Jad, Nabizadeh, Jamileh, Panagides, Nadya and Rolfe, Barbara E. (2024). The role of the complement system in cancer etiology and management. Clinical immuno-oncology. (pp. 41-60.e10) edited by John E. Niederhuber. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-323-87763-3.00012-5 |
|
2022 Book Chapter Neuroinflammation in Huntington’sLee, John D., Lo, Martin W., Fung, Jenny N. T. and Woodruff, Trent M. (2022). Neuroinflammation in Huntington’s. Neurodegenerative Diseases Biomarkers. (pp. 215-233) edited by Philip V. Peplow, Bridget Martinez and Thomas A. Gennarelli. New York, NY, United States: Springer US. doi: 10.1007/978-1-0716-1712-0_9 |
|
2018 Book Chapter C3aR1Coulthard, Liam G., Hawksworth, Owen A. and Woodruff, Trent M. (2018). C3aR1. The complement FactsBook. (pp. 385-396) edited by Scott Barnum and Theresa Schein. London, United Kingdom: Elsevier. doi: 10.1016/B978-0-12-810420-0.00036-5 |
|
2018 Book Chapter C5aR1Coulthard, Liam G., Hawksworth, Owen A. and Woodruff, Trent M. (2018). C5aR1. The Complement FactsBook. (pp. 397-405) edited by Scott Barnum and Theresa Schein. London, United Kingdom: Academic Press. doi: 10.1016/B978-0-12-810420-0.00037-7 |
|
2018 Book Chapter C5aR2Coulthard, Liam G., Hawksworth, Owen A. and Woodruff, Trent M. (2018). C5aR2. The complement FactsBook. (pp. 407-414) edited by Scott Barnum and Theresa Schein. London, United Kingdom: Academic Press. doi: 10.1016/B978-0-12-810420-0.00038-9 |
|
2018 Book Chapter Inflammasomes in CNS diseasesAlbornoz, Eduardo A., Woodruff, Trent M. and Gordon, Richard (2018). Inflammasomes in CNS diseases. Inflammasomes: clinical and therapeutic implications. (pp. 41-60) edited by Mario D. Cordero and Elisabet Alcocer-Gómez. Cham, Switzerland: Springer International. doi: 10.1007/978-3-319-89390-7_3 |
|
2017 Book Chapter Neuroinflammation as a therapeutic target in neurodegenerative diseasesGordon, Richard and Woodruff, Trent M. (2017). Neuroinflammation as a therapeutic target in neurodegenerative diseases. Disease-modifying targets in neurodegenerative disorders: paving the way for disease-modifying therapies. (pp. 49-80) edited by Veerle Baekelandt and Evy Lobbestael. London, United Kingdom: Academic Press. doi: 10.1016/B978-0-12-805120-7.00003-8 |
|
2017 Book Chapter Neuroinflammation as a therapeutic target in neurodegenerative diseasesGordon, Richard and Woodruff, Trent M. (2017). Neuroinflammation as a therapeutic target in neurodegenerative diseases. Disease-modifying targets in neurodegenerative disorders. (pp. 43-64) edited by Veerle Baekelandt and Evy Lobbestael. Boston, MA, United States: Academic Press (Elsevier Press). |
|
2012 Book Chapter Innate immunity in ALSLee, John D., Lee, Jia Y., Taylor, Stephen M., Noakes, Peter G. and Woodruff, Trent M. (2012). Innate immunity in ALS. Amyotrophic lateral sclerosis. (pp. 393-412) edited by Martin H. Maurer. Croatia: InTech - Open Access Publisher. doi: 10.5772/30341 |
|
2006 Book Chapter Transdermal Pharmacology of Small Molecule Cyclic C5a AntagonistsProctor, Lavinia M., Woodruff, Trent M., Sharma, Prakirti, Shiels, Ian A., Taylor, Stephen M. and Lambris, John D. (2006). Transdermal Pharmacology of Small Molecule Cyclic C5a Antagonists. Current Topics in Complement. (pp. 329-345) edited by John D. Lambris. New York: Springer. doi: 10.1007/0-387-34134-X_22 |
